Keros Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $7.2M | 181k | 39.76 |
| 2023-09-30 | $210k | 6.6k | 31.88 |
| 2023-06-30 | $1.2M | 30k | 40.18 |
| 2023-03-31 | $1.4M | 33k | 42.70 |
| 2022-12-31 | $2.4M | 49k | 48.02 |
| 2022-09-30 | $6.2M | 163k | 37.68 |
| 2022-06-30 | $5.4M | 197k | 27.61 |
| 2022-03-31 | $11M | 200k | 54.32 |
| 2021-12-31 | $9.1M | 156k | 58.45 |
| 2021-09-30 | $5.1M | 130k | 39.60 |
| 2021-06-30 | $60k | 1.4k | 42.25 |
| 2021-03-31 | $958k | 16k | 61.54 |
| 2020-12-31 | $18k | 249 | 72.29 |
| 2020-06-30 | $83k | 2.2k | 37.61 |